Evaluation of Solanidine as an Exogenous Biomarker to Phenotype CYP2D6 Activity in Humans

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Solanidine as an Exogenous Biomarker to Phenotype CYP2D6 Activity in Humans	Pharmacokinetic Study in Healthy Volunteers	Not yet recruiting	Not applicable	2026-09-14		NCT07817030

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Medicine Greifswald	23

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Medicine Greifswald	Greifswald	Germany	1

Clinical trials